Supplementary Methods, Figures 1-9, Table 1 from rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 155K
Authors: Xiaowen Ge, Lin Wu, Weiguo Hu, Stacey Fernandes, Chun Wang, Xu Li, Jennifer R. Brown, Xuebin Qin
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361881292